Get the Stockscreener App
8.00
13.96%
0.98
Briacell Therapeutics Corp stock is traded at $8.00, with a volume of 38,328.
It is up +13.96% in the last 24 hours and down -37.35% over the past month.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
See More
Previous Close:
$7.02
Open:
$7.29
24h Volume:
38,328
Relative Volume:
0.39
Market Cap:
$15.07M
Revenue:
-
Net Income/Loss:
$-26.56M
P/E Ratio:
-0.1809
EPS:
-44.2199
Net Cash Flow:
$-28.59M
1W Performance:
-12.71%
1M Performance:
-37.35%
6M Performance:
+125.35%
1Y Performance:
-32.40%
1-Day Range:
$7.10
$8.28
1-Week Range:
$6.93
$9.33
52-Week Range:
$0.61
$19.05
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
8.00 | 13.23M | 0 | -26.56M | -28.59M | -44.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
How to Take Advantage of moves in (BCT) (BCT:CA) - news.stocktradersdaily.com
What analysts say about BriaCell Therapeutics Corp Equity Warrant stockDividend Stability Analysis & Exceptional Capital Trading - earlytimes.in
BriaCell and Receptor.AI Partner on AI- driven Small Molecule Cancer Therapeutics - MarketScreener
BriaCell (BCTX) Partners with Receptor.AI for Innovative Cancer Drug Development - GuruFocus
Briacell and Receptor.AI to collaborate on AI driven small molecule cancer therapeutics - MarketScreener
BriaCell and Receptor.AI Collaborate on AI-Driven Cancer Therapeutics - TipRanks
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics - The Manila Times
BriaCell (NASDAQ: BCTX) and Receptor.AI launch AI-driven kinase inhibitor collaboration - Stock Titan
How BriaCell Therapeutics Corp. stock valuations compare to rivalsProfit Target & AI Forecasted Stock Moves - newser.com
Why analysts maintain buy rating on BriaCell Therapeutics Corp. (8BT0) stockSwing Trade & Trade Opportunity Analysis - newser.com
How buyback programs support BriaCell Therapeutics Corp. (8BT0) stock - newser.com
Why BriaCell Therapeutics Corp. (8BT0) stock trades below fair valueGold Moves & AI Enhanced Trading Alerts - newser.com
Published on: 2025-11-20 01:08:24 - newser.com
Why BriaCell Therapeutics Corp. (8BT0) stock remains top ratedMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
BriaCell Therapeutics Corp. (BCTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Published on: 2025-11-19 11:18:19 - newser.com
Using portfolio simulators with BriaCell Therapeutics Corp. Equity Warrant includedTrend Reversal & Weekly High Conviction Ideas - newser.com
How to interpret RSI for BriaCell Therapeutics Corp. Equity Warrant stockWeekly Gains Summary & Risk Adjusted Swing Trade Ideas - newser.com
Will BriaCell Therapeutics Corp. stock benefit from infrastructure spendingTrade Analysis Report & Verified Swing Trading Watchlist - newser.com
Pattern recognition hints at BriaCell Therapeutics Corp. upsideJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com
How BriaCell Therapeutics Corp. Equity Warrant stock performs in high volatility marketsJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - newser.com
Published on: 2025-11-19 03:48:55 - newser.com
How to manage a losing position in BriaCell Therapeutics Corp. Equity WarrantWeekly Risk Report & Reliable Volume Spike Alerts - newser.com
Trend analysis for BriaCell Therapeutics Corp. Equity Warrant this weekJuly 2025 Gainers & Weekly High Return Forecasts - newser.com
Will BriaCell Therapeutics Corp. Equity Warrant benefit from macro trendsWeekly Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
What MACD and RSI say about BriaCell Therapeutics Corp.Quarterly Market Summary & Verified Momentum Watchlists - newser.com
Is BriaCell Therapeutics Corp. Equity Warrant stock positioned for digital transformationQuarterly Trade Report & Weekly Momentum Picks - newser.com
BriaCell Therapeutics Selected to Present Four Posters at Breast Cancer Symposium - MarketScreener
Is BriaCell Therapeutics Corp. stock attractive for growth ETFsTrade Exit Report & Safe Entry Zone Identification - newser.com
BriaCell to present updated cancer immunotherapy data at SABCS By Investing.com - Investing.com Nigeria
Stocks in play: BriaCell Therapeutics Corp. - The Globe and Mail
BriaCell to Present Key Clinical Data at SABCS 2025 - TipRanks
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):